Intravenous vitamin C use and risk of severity and mortality in COVID-19: A systematic review and meta-analysis.

ABSTRACT: The administration of intravenous vitamin C (IV-VC) in treating patients with coronavirus disease 2019 (COVID-19) is still highly controversial. There have been no previous studies on the effect of IV-VC on the severity and mortality of COVID-19. Hence, we conducted a systematic review and meta-analysis to compare the disease severity and mortality in patients with COVID-19 who promptly received IV-VC treatment vs those who did not. We performed a comprehensive systematic search of seven health science databases, including PubMed, Embase, Cochrane Library, MEDLINE, Web of Science, China National Knowledge Infrastructure, and Wanfang Data, up to June 23, 2021. We identified a total of seven related articles, which were included in this study. This meta-analysis showed that IV-VC treatment d

SUBMITTER: Ao G 

PROVIDER: S-EPMC9088481 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature